Evidence map›Paper›PMID 27826469›Full record

ArticlePlastic and reconstructive surgery. Global open2016

A Novel Reticular Dermal Graft Leverages Architectural and Biological Properties to Support Wound Repair.

Anouska Dasgupta, Dennis Orgill, Robert D Galiano, Charles M Zelen, Yen-Chen Huang, Evangelia Chnari, William W Li

Open access · goldAbstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anouska DasguptaMusculoskeletal Transplant Foundation, Edison, N.J.; Department of Surgery, Brigham and Women's Hospital, Boston, Mass.; Department of Surgery, Harvard Medical School, Boston, Mass.; Division of Plastic Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.; Professional Education and Research Institute, Roanoke, Va.; and The Angiogenesis Foundation, Cambridge, Mass.
Dennis OrgillMusculoskeletal Transplant Foundation, Edison, N.J.; Department of Surgery, Brigham and Women's Hospital, Boston, Mass.; Department of Surgery, Harvard Medical School, Boston, Mass.; Division of Plastic Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.; Professional Education and Research Institute, Roanoke, Va.; and The Angiogenesis Foundation, Cambridge, Mass.
Robert D GalianoMusculoskeletal Transplant Foundation, Edison, N.J.; Department of Surgery, Brigham and Women's Hospital, Boston, Mass.; Department of Surgery, Harvard Medical School, Boston, Mass.; Division of Plastic Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.; Professional Education and Research Institute, Roanoke, Va.; and The Angiogenesis Foundation, Cambridge, Mass.
Charles M ZelenMusculoskeletal Transplant Foundation, Edison, N.J.; Department of Surgery, Brigham and Women's Hospital, Boston, Mass.; Department of Surgery, Harvard Medical School, Boston, Mass.; Division of Plastic Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.; Professional Education and Research Institute, Roanoke, Va.; and The Angiogenesis Foundation, Cambridge, Mass.
Yen-Chen HuangMusculoskeletal Transplant Foundation, Edison, N.J.; Department of Surgery, Brigham and Women's Hospital, Boston, Mass.; Department of Surgery, Harvard Medical School, Boston, Mass.; Division of Plastic Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.; Professional Education and Research Institute, Roanoke, Va.; and The Angiogenesis Foundation, Cambridge, Mass.
Evangelia ChnariMusculoskeletal Transplant Foundation, Edison, N.J.; Department of Surgery, Brigham and Women's Hospital, Boston, Mass.; Department of Surgery, Harvard Medical School, Boston, Mass.; Division of Plastic Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.; Professional Education and Research Institute, Roanoke, Va.; and The Angiogenesis Foundation, Cambridge, Mass.
William W LiMusculoskeletal Transplant Foundation, Edison, N.J.; Department of Surgery, Brigham and Women's Hospital, Boston, Mass.; Department of Surgery, Harvard Medical School, Boston, Mass.; Division of Plastic Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.; Professional Education and Research Institute, Roanoke, Va.; and The Angiogenesis Foundation, Cambridge, Mass.
Brigham and Women's Hospital · USNorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcellular dermal matrices (ADMs) are frequently used in reconstructive surgery and as scaffolds to treat chronic wounds. The 3-dimensional architecture and extracellular matrix provide structural and signaling cues for repair and remodeling. However, most ADMs are not uniformly porous, which can lead to heterogeneous host engraftment. In this study, we hypothesized that a novel human reticular ADM (HR-ADM; AlloPatch Pliable, Musculoskeletal Transplant Foundation, Edison, N.J.) when aseptically processed would have a more open uniform structure with retention of biological components known to facilitate wound healing.

methodsThe reticular and papillary layers were compared through histology and scanning electron microscopy. Biomechanical properties were assessed through tensile testing. The impact of aseptic processing was evaluated by comparing unprocessed with processed reticular grafts. In vitro cell culture on fibroblasts and endothelial cells were performed to showcase functional cell activities on HR-ADMs.

resultsAseptically processed HR-ADMs have an open, interconnected uniform scaffold with preserved collagens, elastin, glycosaminoglycans, and hyaluronic acid. HR-ADMs had significantly lower ultimate tensile strength and Young's modulus versus the papillary layer, with a higher percentage elongation at break, providing graft flexibility. These preserved biological components facilitated fibroblast and endothelial cell attachment, cell infiltration, and new matrix synthesis (collagen IV, fibronectin, von Willebrand factor), which support granulation and angiogenic activities.

conclusionsThe novel HR-ADMs provide an open, interconnected scaffold with native dermal mechanical and biological properties. Furthermore, aseptic processing retains key extracellular matrix elements in an organized framework and supports functional activities of fibroblasts and endothelial cells.

Identifiers

PMID27826469
PMCPMC5096524
OpenAlexW2528932971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.